CMS Makes Policy Waves With Pullback Of Longstanding TENS Coverage

The new finalized coverage policy for transcutaneous electrical nerve stimulation for treating chronic back pain is a rare decision by the agency to reverse coverage on an established technology, and is a new direction for the coverage-with-evidence-development program, observers say.

More from Policy & Regulation

More from Medtech Insight